WVP
ICPT

Worth Venture Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Worth Venture Partners’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-93,700
Closed -$8K – 213
2022
Q3 		$8K Buy
93,700
+45,900
+96% +$739K ﹤0.01% 165
2022
Q2 		$32K Buy
+47,800
New +$765K 0.02% 134
2019
Q3 		– Sell
-700
Closed -$1K – 121
2019
Q2 		$1K Hold
700
– – ﹤0.01% 95
2019
Q1 		$1K Hold
700
– – ﹤0.01% 97
2018
Q4 		$4K Hold
700
– – ﹤0.01% 90
2018
Q3 		$2K Sell
700
-500
-42% -$52.9K ﹤0.01% 167
2018
Q2 		$5K Buy
+1,200
New +$87.9K ﹤0.01% 89

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return